13 withdrawn. 13 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 13 | Withdrawn 13 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Neuroblastoma: new trials by email Literature Review of Neuroblastoma trials Research Report on Neuroblastoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma Biospecimen Collection, Computed Tomography, Florbenguane F18 - Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular | Phase 2 | Withdrawn | Children's Oncology Group | 2026-09-22 | 2026-09-16 | |
| 18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System 18F-mFBG - Neuroblastoma, Pheochromocytoma | Phase 2 | Withdrawn | Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) | 2025-01-01 | 2025-01-21 | |
| A Phase II Study of Rivoceranib for Patients With Recurrent or Metastatic Olfactory Neuroblastoma Rivoceranib - Metastatic Olfactory Neuroblastoma, Recurrent Olfactory Neuroblastoma | Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2024-11-01 | 2025-01-10 | |
| Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma Defibrotide - Transplant-Associated Thrombotic Microangiopathy, Neuroblastoma | Phase 2 | Withdrawn | University of California, San Francisco | 2024-08-01 | 2024-08-07 | |
| Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GMCSF) and Isotretinoin for Consolidation of Patients With High-Risk Neuroblastoma in First Remission. Naxitamab, GM-CSF, Isotretinoin - Neuroblastoma | Phase 2 | Withdrawn | Y-mAbs Therapeutics | 2021-12-02 | 2022-09-01 | |
| Dosimetry Guided PRRT With 90Y-DOTATOC 90Y-DOTA-3-tyr-Octreotide, Positron Emission Tomography (PET) whole body scan, Amino Acids - Neuroendrocrine Tumors, Meningioma | Phase 2 | Withdrawn | Sue O'Dorisio | 2017-01-01 | 2017-08-25 | |
| Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors Imetelstat Sodium, Laboratory Biomarker Analysis - Hepatoblastoma, Previously Treated Childhood Rhabdomyosarcoma | Phase 2 | Withdrawn | Children's Oncology Group | 2014-06-30 | 2018-08-07 | |
| New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma New Castle Disease Virus - Glioblastoma, Sarcoma | Phase 1 / Phase 2 | Withdrawn | Hadassah Medical Organization | 2011-07-01 | 2015-06-11 | |
| Efficacy and Safety of Ultratrace™ Iobenguane I 131 in Neuroblastoma Ultratrace Iobenguane I 131 - Neuroblastoma | Phase 2 | Withdrawn | Molecular Insight Pharmaceuticals, Inc. | 2010-01-01 | 2015-11-26 | |
| 90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET) Retinoic Acid, Placebo - Neuroblastoma, Neuroendocrine Tumor | Phase 2 | Withdrawn | University of Iowa | 2009-06-01 | 2016-06-21 | |
| Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL. anti-thymocyte globulin, busulfan, cyclosporine - Neuroblastoma | Phase 2 | Withdrawn | Nationwide Children's Hospital | 2008-09-01 | 2015-10-16 | |
| High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk Neuroblastoma iodine I 131 metaiodobenzylguanidine, topotecan hydrochloride, chemotherapy - Neuroblastoma | Phase 2 | Withdrawn | Children's Cancer and Leukaemia Group | 2008-07-01 | 2013-07-10 | |
| Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor filgrastim, carboplatin, cisplatin - Brain and Central Nervous System Tumors, Neuroblastoma | Phase 2 | Withdrawn | NYU Langone Health | 1997-11-01 | 2015-12-03 |
Recurrence (2) · Sarcoma (2) · Central Nervous System Neoplasms (1) · Choroid Plexus Neoplasms (1) · Esthesioneuroblastoma, Olfactory (1) · Ganglioneuroblastoma (1) · Glioblastoma (1) · Hepatoblastoma (1) · Medulloblastoma (1) · Meningioma (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Neuroectodermal Tumors, Primitive, Peripheral (1) · Neuroendocrine Tumors (1)
Neoplasms by Histologic Type (13) · Neoplasms, Germ Cell and Embryonal (13) · Neoplasms, Glandular and Epithelial (13) · Neoplasms, Nerve Tissue (13) · Neoplasms, Neuroepithelial (13) · Neuroectodermal Tumors (13) · Neuroectodermal Tumors, Primitive (13) · Neoplasms (12) · Neuroectodermal Tumors, Primitive, Peripheral (12) · Neoplasms, Connective and Soft Tissue (3) · Nervous System Diseases (3) · Disease Attributes (2) · Glioma (2) · Neoplasms by Site (2) · Nervous System Neoplasms (2)
3-fluorobenzylguanidine (2) · Isotretinoin (2) · Magnetic Resonance Spectroscopy (2) · Peripheral Blood Stem Cell Transplantation (2) · 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (1) · 3-Iodobenzylguanidine (1) · 90Y-octreotide, DOTA-Tyr(3)- (1) · Amino Acids (1) · Antilymphocyte Serum (1) · Busulfan (1) · Carboplatin (1) · Cisplatin (1) · Cyclophosphamide (1) · Cyclosporine (1) · Cyclosporins (1)
Children's Oncology Group (2) · Children's Cancer and Leukaemia Group (1) · Hadassah Medical Organization (1) · Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) (1) · M.D. Anderson Cancer Center (1) · Molecular Insight Pharmaceuticals, Inc. (1) · NYU Langone Health (1) · Nationwide Children's Hospital (1) · Sue O'Dorisio (1) · University of California, San Francisco (1) · University of Iowa (1) · Y-mAbs Therapeutics (1)
United States (5) · Canada (2) · Argentina (1) · Hong Kong (1) · Israel (1) · Russia (1) · Singapore (1) · South Korea (1)
Alice Lee, MD (1) · Christine Higham, MD (1) · Jonathan L. Finlay, MB, ChB (1) · Luana Guimaraes De Sousa, MD (1) · M S O'Dorisio, MD, PhD (1) · M Sue O'Dorisio, MD, PhD (1) · Mark N. Gaze, MD (1) · Norman LaFrance, MD (1) · Patrick Thompson (1) · Reuven Or, MD (1) · Sandeep Soni, MD (1) · Tanya C Watt (1)
R01CA167632 (1), U10CA098543 (1), UM1CA228823 (1)